CD47 and cancer: CD47-functionalized MSC EVs carrying KRASG12D siRNA are a promising vehicle for reducing KRAS expression in patient-derived xenograft mice, resulting in cancer cell apoptosis, inhibition of metastasis, and increased overall survival without cytotoxic effect [67].